Evidence map›Paper›PMID 42711487›Full record

ArticleNature2026

Author Correction: Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.

Panagiotis Ntziachristos, Aristotelis Tsirigos, G Grant Welstead, Thomas Trimarchi, Sofia Bakogianni, Luyao Xu, Evangelia Loizou, Linda Holmfeldt, Alexandros Strikoudis, Bryan King and 16 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Panagiotis Ntziachristos *Howard Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Aristotelis Tsirigos *Howard Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA. Aristotelis.Tsirigos@nyumc.org.
G Grant WelsteadWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
Thomas TrimarchiHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Sofia BakogianniHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Luyao XuInstitute for Cancer Genetics, Columbia University Medical Center, New York, New York, USA.
Evangelia LoizouHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Linda HolmfeldtDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Alexandros StrikoudisHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Bryan KingHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Jasper MullendersHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Jared BecksfortDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jelena NedjicHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA.
Elisabeth PaiettaMontefiore Medical Center North, Bronx, New York, New York, USA.
Martin S TallmanMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Jacob M RoweTechnion, Israel Institute of Technology, Haifa, Israel.
Giovanni TononDivision of Molecular Oncology, Functional Genomics of Cancer Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
Takashi SatohLaboratory of Host Defense, WPI Immunology Frontier Research Center (WPI IFReC), Osaka University, Suita, Osaka, Japan.
Laurens KruidenierEpinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK.
Rab PrinjhaEpinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK.
Shizuo AkiraLaboratory of Host Defense, WPI Immunology Frontier Research Center (WPI IFReC), Osaka University, Suita, Osaka, Japan.
Pieter Van VlierbergheInstitute for Cancer Genetics, Columbia University Medical Center, New York, New York, USA.
Adolfo A FerrandoInstitute for Cancer Genetics, Columbia University Medical Center, New York, New York, USA.
Rudolf JaenischWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
Charles G MullighanDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. charles.mullighan@stjude.org.
Iannis AifantisHoward Hughes Medical Institute and Department of Pathology, NYU School of Medicine, New York, New York, USA. Iannis.Aifantis@nyumc.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42711487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.